Literature DB >> 8755008

Thrombolytic therapy in infants for femoral artery thrombosis following cardiac catheterisation.

S S Kothari1, R K Kumar, S Varma, A Saxena.   

Abstract

Little information is available on the use of thromobolytic therapy in infants for femoral artery thrombosis after cardiac catheterisation. We report 12 cases (mean age: 4 months; range: 1-9 months) who received intravenous streptokinase (3000 U/kg bolus, 1000 U/kg/h) infusion. Five of them had undergone transarterial balloon dilatation procedures. Streptokinase was administered 48 h after catheterisation and continued for 4-20 h (mean 11.5 h). No detailed haematologic monitoring was done during therapy. Distal pulses were restored in all the patients. No complications were seen except a minor local ooze in two patients. We found that intravenous streptokinase is a safe and effective therapy for femoral artery thrombosis following cardiac catheterisation in infants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755008

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  2 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  The effects of ranitidine and hydrocortisone on the complications of femoral artery obstruction treated by streptokinase following cardiac catheterization in pediatric patients with congenital heart diseases.

Authors:  Noormohammad Noori; Ghasem Miri Aliabad; Mehdi Mohammadi; Maziar Mahjoubifard; Alireza Jahangiri Fard
Journal:  Iran Red Crescent Med J       Date:  2013-02-05       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.